Table 2.

Fibromodulin gene expression in freshly isolated tumor cells of patients with hematologic malignancies and in nucleated blood cells of healthy control donors


Tumor or normal cells by tissue type

No. positive/total no. cases
Peripheral blood  
B-CLL   75/75  
Mantle cell lymphoma   5/7  
B-PLL   0/1  
T-CLL   0/5  
T-PLL   0/1  
Hairy cell leukemia   0/10  
CML   0/15  
AML   0/5  
ALL   0/14  
Bone marrow  
B-CLL   2/2  
Follicular lymphoma   0/2  
Lymphoplasmacytic lymphoma   0/4  
Multiple myeloma   0/4  
Normal PBMCs, lymphocytes and monocytes   0/70  
Normal blood B lymphocytes*  0/6  
Normal tonsil B lymphocytes*  0/2  
Normal blood granulocytes  0/10  
Normal blood T lymphocytes
 
0/4
 

Tumor or normal cells by tissue type

No. positive/total no. cases
Peripheral blood  
B-CLL   75/75  
Mantle cell lymphoma   5/7  
B-PLL   0/1  
T-CLL   0/5  
T-PLL   0/1  
Hairy cell leukemia   0/10  
CML   0/15  
AML   0/5  
ALL   0/14  
Bone marrow  
B-CLL   2/2  
Follicular lymphoma   0/2  
Lymphoplasmacytic lymphoma   0/4  
Multiple myeloma   0/4  
Normal PBMCs, lymphocytes and monocytes   0/70  
Normal blood B lymphocytes*  0/6  
Normal tonsil B lymphocytes*  0/2  
Normal blood granulocytes  0/10  
Normal blood T lymphocytes
 
0/4
 

Fibromodulin expression was determined using RT-PCR.

*

Purity >90%.

Purity >98%.

Purity >70%.

Close Modal

or Create an Account

Close Modal
Close Modal